Literature DB >> 15569962

Is lipid-lowering therapy underused by African Americans at high risk of coronary heart disease within the VA health care system?

LeChauncy D Woodard1, Nancy R Kressin, Laura A Petersen.   

Abstract

OBJECTIVES: We examined whether racial differences exist in cholesterol monitoring, use of lipid-lowering agents, and achievement of guideline-recommended low-density lipoprotein (LDL) levels for secondary prevention of coronary heart disease.
METHODS: We reviewed charts for 1045 African American and White patients with coronary heart disease at 5 Veterans Affairs (VA) hospitals.
RESULTS: Lipid levels were obtained in 67.0% of patients. Whites and African Americans had similar screening rates and mean lipid levels. Among the 544 ideal candidates for therapy, rates of treatment and achievement of target LDL levels were similar.
CONCLUSIONS: We found no disparities in cholesterol management. This absence of disparities may be the result of VA quality improvement initiatives or prescription coverage through the VA health care system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569962      PMCID: PMC1448600          DOI: 10.2105/ajph.94.12.2112

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  43 in total

Review 1.  Risk factors and the natural history of coronary heart disease in blacks.

Authors:  C E Lewis; J M Raczynski; A Oberman; G R Cutter
Journal:  Cardiovasc Clin       Date:  1991

2.  Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease.

Authors:  J Pekkanen; S Linn; G Heiss; C M Suchindran; A Leon; B M Rifkind; H A Tyroler
Journal:  N Engl J Med       Date:  1990-06-14       Impact factor: 91.245

3.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Authors: 
Journal:  JAMA       Date:  1993-06-16       Impact factor: 56.272

4.  Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system.

Authors:  J Whittle; J Conigliaro; C B Good; R P Lofgren
Journal:  N Engl J Med       Date:  1993-08-26       Impact factor: 91.245

5.  Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.

Authors:  J D Neaton; H Blackburn; D Jacobs; L Kuller; D J Lee; R Sherwin; J Shih; J Stamler; D Wentworth
Journal:  Arch Intern Med       Date:  1992-07

6.  Correlation of serum lipids with the presence or absence of coronary artery disease in 1,793 men and women aged > or = 62 years.

Authors:  W S Aronow; C Ahn
Journal:  Am J Cardiol       Date:  1994-04-01       Impact factor: 2.778

7.  Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veterans Affairs.

Authors:  E D Peterson; S M Wright; J Daley; G E Thibault
Journal:  JAMA       Date:  1994-04-20       Impact factor: 56.272

8.  Serum cholesterol in young men and subsequent cardiovascular disease.

Authors:  M J Klag; D E Ford; L A Mead; J He; P K Whelton; K Y Liang; D M Levine
Journal:  N Engl J Med       Date:  1993-02-04       Impact factor: 91.245

9.  Risk factors for long-term coronary prognosis after initial myocardial infarction: the Framingham Study.

Authors:  N D Wong; L A Cupples; A M Ostfeld; D Levy; W B Kannel
Journal:  Am J Epidemiol       Date:  1989-09       Impact factor: 4.897

10.  Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study.

Authors:  W P Newman; D S Freedman; A W Voors; P D Gard; S R Srinivasan; J L Cresanta; G D Williamson; L S Webber; G S Berenson
Journal:  N Engl J Med       Date:  1986-01-16       Impact factor: 91.245

View more
  9 in total

Review 1.  Cardiovascular health disparities: a systematic review of health care interventions.

Authors:  Andrew M Davis; Lisa M Vinci; Tochi M Okwuosa; Ayana R Chase; Elbert S Huang
Journal:  Med Care Res Rev       Date:  2007-10       Impact factor: 3.929

2.  Lifestyle therapy changes and hypercholesterolemia: identifying risk groups in a community sample of Blacks and Whites.

Authors:  Rhonda BeLue; Stephanie T Lanza; M Kathleen Figaro
Journal:  Ethn Dis       Date:  2009       Impact factor: 1.847

3.  Appropriateness of cholesterol management in primary care by sex and level of cardiovascular risk.

Authors:  Ann Hiott Barham; David C Goff; Haiying Chen; Aarthi Balasubramanyam; Erica Rosenberger; Denise E Bonds; Alain G Bertoni
Journal:  Prev Cardiol       Date:  2009

4.  Assessment of racial disparities in chronic kidney disease stage 3 and 4 care in the department of defense health system.

Authors:  Sam W Gao; David K Oliver; Neal Das; Frank P Hurst; Krista L Lentine; Lawrence Y Agodoa; Eric S Sawyers; Kevin C Abbott
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-16       Impact factor: 8.237

Review 5.  Racial and ethnic disparities in the VA health care system: a systematic review.

Authors:  Somnath Saha; Michele Freeman; Joahd Toure; Kimberly M Tippens; Christine Weeks; Said Ibrahim
Journal:  J Gen Intern Med       Date:  2008-02-27       Impact factor: 5.128

6.  Temporal Trends of High-Intensity Statin Therapy Among Veterans Treated With Percutaneous Coronary Intervention.

Authors:  Aref A Bin Abdulhak; Mary Vaughan-Sarrzin; Peter Kaboli; Phillip A Horwitz; Hilary Mosher; Gardar Sigurdsson; Nicholas E Walker; Robert Wallace; Jennifer G Robinson
Journal:  J Am Heart Assoc       Date:  2018-03-04       Impact factor: 5.501

7.  Racial-Geographic Disparity in Lipid Management in Veterans with Type 2 Diabetes: A 10-Year Retrospective Cohort Study.

Authors:  Elizabeth A Brown; Ralph C Ward; Erin Weeda; David J Taber; Robert Neal Axon; Mulugeta Gebregziabher
Journal:  Health Equity       Date:  2019-09-23

8.  Impact of Race and Location of Residence on Statin Treatment Among Veterans With Type 2 Diabetes Mellitus.

Authors:  Erin R Weeda; Kinfe G Bishu; Ralph C Ward; Elizabeth A Brown; R Neal Axon; David J Taber; Mulugeta Gebregziabher
Journal:  Am J Cardiol       Date:  2020-03-05       Impact factor: 2.778

9.  Racial/Ethnic Disparities in VA Services Utilization as a Partial Pathway to Mortality Differentials Among Veterans Diagnosed With TBI.

Authors:  Clara E Dismuke; Mulugeta Gebregziabher; Leonard E Egede
Journal:  Glob J Health Sci       Date:  2015-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.